The binding of plasmid DNA to norfloxacin, a quinolone antibacterial agent, was investigated by fluorescence, electrophoretic DNA unwinding, and affinity chromatography techniques. The amount of quinolone bound to DNA was modulated by the concentration of Mg2+. No interaction was evident in the absence of Mg2+ or in the presence of an excess of Mg2+, whereas maximum binding was observed at a Mg2+ concentration of 1-2 mM. The experimental data can be fitted to the formation of three types of Mg adducts: a binary adduct with norfloxacin and Mg2+, a binary adduct with DNA and Mg2+, and a ternary adduct with quinolone, plasmid, and Mg2+. We propose a model for the ternary complex, in which Mg acts as a bridge between the phosphate groups of the nucleic acid and the carbonyl and carboxyl moieties of norfloxacin. Additional stabilization may arise from stacking interactions between the condensed rings of the drug and DNA bases (especially guanine and adenine), which may account for the preference exhibited by quinolones for single-stranded and purine-rich regions ofnucleic acids. Other possible biochemical pathways of drug action are suggested by the observation that norfloxacin binds Mg2+ under conditions that are close to physiological.
Mg acts as a bridge between the phosphate groups of the nucleic acid and the carbonyl and carboxyl moieties of norfloxacin. Additional stabilization may arise from stacking interactions between the condensed rings of the drug and DNA bases (especially guanine and adenine), which may account for the preference exhibited by quinolones for single-stranded and purine-rich regions ofnucleic acids. Other possible biochemical pathways of drug action are suggested by the observation that norfloxacin binds Mg2+ under conditions that are close to physiological.
Conflicting literature reports have been accumulating on the role played by DNA in the mechanism of action of quinolone compounds. Although a large amount of biological data has indicated that DNA gyrase was the target for quinolone compounds (1) (2) (3) (4) , recent reports dismissed DNA gyrase as the target and pointed to DNA as the direct binding species (5) . In fact, a cooperative interaction was proposed to occur between quinolones and supercoiled DNA. Subsequent publications by the same laboratory have modified this view extensively (6) (7) (8) . In particular, Shen et al. (7) have proposed that in the presence of ATP bound gyrase induces a specific quinolone binding site in the relaxed DNA substrate. Gelelectrophoresis experiments by Tornaletti and Pedrini (9) showed that norfloxacin (Nor) is able to unwind the DNA double helix in the presence of Mg2+. On the other hand 19F
NMR measurements failed to show any direct DNAquinolone interaction (10) . We were also unable to detect binding using fluorescence spectroscopy techniques (11) .
Even if reconsidered in terms of affinity, the interaction with DNA is still of great concern because of the possible long-term genotoxicity of quinolone compounds, which are increasingly adopted as first-choice antibiotics for the treatment of many infections, and because it addresses the real mechanism of action of this class of molecules. To shed some light on this cumbersome problem, we have focused our attention on the role of Mg2+ in the binding of the model quinolone drug Nor to plasmid DNA. Our approach includes fluorescence and affinity chromatography measurements and electrophoretic DNA-unwinding assays.
MATERIALS AND METHODS
Chemicals. Nor and [14C]Nor (specific activity, 46.5 ,uCi/ mg; 1 Ci = 37 GBq) were a kind gift of Merck Sharp & Dohme. Magnesium chloride and perchlorate were purchased from Fluka.
Substrate DNAs. pAT153 and pBR322 were propagated by conventional methods (12) . Naturally supercoiled DNA was purified on CsCl and sucrose gradients as described (12) .
DNA-cellulose resins were prepared by absorbing plasmid DNA onto the cellulose matrix and covalently linking it by UV-irradiation as described (13) . The DNA-cellulose derivative contained 2.1-5.3 mg of DNA per gram of resin as described (13, 14) .
DNA Unwinding. Unwinding experiments in the presence of quinolone compounds were performed using a DNA circle-ligation assay essentially as described (15) . Briefly, 100 ng of nicked circular pAT153 substrate was exposed to 1 unit of T4 DNA ligase in 66 mM Tris-HCl/various amounts of MgCl2/10 mM dithioerythritol/0.7 mM ATP, pH 7.5, in the presence of known drug concentrations. After incubation at 0°C for 10 min, the reaction was stopped by addition of20 mM EDTA. Samples that had been extracted with butanol were loaded onto 1% agarose gels containing chloroquine (0.94 ,g/ml). The average linking number of each ligated population of topoisomers was calculated after densitometric scanning of ethidium bromide-stained gels (15) .
DNA Affinity Chromatography.
[14C]Nor (5000 cpm/nmol) was run through a DNA-cellulose column prepared as described above. The loading buffer contained 10 mM Tris HCI (pH 7.0), 20 mM NaCl, and various concentrations of Mg2 . The concentration of the bivalent metal ion was determined by atomic absorption spectrometry measurements. The amount of quinolone bound to the column was calculated from the radioactivity retained in the column after repeated washings with loading buffer. Control experiments were done to exclude aspecific drug absorption onto the column. The data were further confirmed by elution of the column-bound drug with the loading buffer containing an excess (50-100 mM) of either Mg2+ or EDTA.
Some of the measurements were also performed using the fluorescence response of Nor to determine quantitatively the eluted quinolone. Standard 
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RESULTS
Nor Binds to Mg2+ Ions. The fluorescence emission of Nor is remarkably increased by addition of Mg2+ ions at neutral pH ( Fig. 1) . Saturation occurs at a Mg2+ concentration of =10 mM and is slightly influenced by ionic strength at room temperature. As the fluorescence response of Nor and of its Mg complex at 423 nm is linear with concentration in the range we examined (up to a few micromolar), the binding constant can be evaluated, by assuming a 1:1 complex, as suggested by the large excess of Mg2+ used with reference to Nor. The association constant K1 in 20 mM NaCl/10 mM Tris HCl, pH 7.0, is 990 ± 36 M-1. Increasing ionic strength causes a moderate decrease in K, to =890 M-1 in 150 mM salt.
Nor Binding to Plasmid DNA Is Mediated by Mg2+. Fluorescence experiments. The fluorescence intensity of Nor between 0.1 and 1 ,uM in the presence ofexcess pBR322 DNA remains practically unaffected in the absence of Mg2+ or in an excess of Mg2+. This is in agreement with our previous findings (11) and indicates that no evidence for binding to DNA is obtained under the above experimental conditions. However, at a Mg2+ concentration in the millimolar range, a DNA-concentration-dependent quenching of Nor fluorescence occurs. Fig. 1 shows the fluorescence response in the presence and absence of plasmid as a function of Mg2+ concentration. Quenching of the fluorescence has been reported by Shen (29) to 88 nM plasmid) is =0.16 ,uM, which corresponds to =2 molecules per plasmid.
Binding measurements were also performed as a function of DNA concentration at a fixed Mg2+ concentration (1 mM). The data are presented in Fig. 2 
angle is close to 12500, which corresponds to some 175 molecules per plasmid DNA. This is in good agreement with the data of Shen et al. (6) . In fact according to the Hill equation reported by them, at a Nor concentration of 133 ,uM, the number of drug molecules bound per plasmid would be 180.
DNA affinity chromatography. The amount of drug bound to the plasmid DNA resin was also evaluated as a function of Mg2+ concentration (Fig. 4) . In confirmation of the data presented above, no appreciable binding was observed at low and high concentrations of bivalent metal ion, whereas the maximum level of drug binding occurs at 2-3 mM Mg2+, at which about three molecules of Nor were bound per plasmid molecule under our experimental conditions. A further indication ofthe role played by Mg2+ in mediating the quinolone-DNA interaction is the observed ability of an excess of Mg2+ or EDTA (-50 mM) to elute the bound drug efficiently and quantitatively. Experiments were also performed to characterize whether the interaction between Nor and plasmid DNA was taking place in a cooperative manner. The radiolabeled Nor could be varied over a wide range of concentrations at a constant Mg2+ concentration and no evidence of cooperativity was observed, as shown in Fig. 5 , where the amount of resin-bound Nor is reported as a function of loaded drug. In fact a linear relationship was found that eventually reached a plateau under saturation conditions. DISCUSSION An extensive investigation has been carried out by Shen and coworkers (5-8) on the mechanism of inhibition of DNA gyrase and DNA binding by quinolone antibacterial agents. They proposed that a form of specific, saturable, and highly cooperative binding takes place with supercoiled DNA or with relaxed DNA-DNA gyrase complexes in the presence of ATP. The quinolone would bind to separated DNA strands through hydrogen bonds between the bases and its carbonyl and carboxyl groups. High binding affinity would be acquired via a cooperative mechanism whereby (as for Nor) four drug molecules interact by ir-ir ring stacking of the quinolone aromatic moiety and tail-to-tail hydrophobic interactions involving the N-ethyl groups.
In a preliminary investigation using fluorometric and radiometric measurements, we were unable to detect the occurrence of quinolone-DNA interaction (11) . Hence, we have tried to clarify the reasons for this discrepancy and also to further analyze the proposed binding model. We realized that the major difference in the experimental conditions between our work and that of Shen and coworkers (6) (7) (8) (-5 mM) . This fact and the finding that DNA-unwinding experiments had to be performed in the presence of Mg2+ (9) suggested that the concentration of Mg2+ could play a role in the formation of the quinolone-DNA complex. This proved to be the case as we found that the extent of Nor binding is modulated by the presence of Mg2+. The modulation was not simply the result of a competition between metal ion and plasmid for binding to Nor, as the extent of drug-DNA complex exhibited a maximum as a function of Mg2+. Thus the first conclusion that can be drawn is that Mg2+ participates in the binding of quinolone to DNA;
i.e., a ternary complex forms involving the drug, the metal ion, and the nucleic acid. We showed that Mg2+ is able to bind to Nor with a stability constant of =4103 M-1. The metal ion binding site probably involves the carbonyl and carboxyl moieties of the quinolone that form a chelate structure.
On the other hand the tendency of Mg2+ to bind to DNA is well documented (17, 18) . The simplest way for the metal ion to generate a ternary complex would be to form a bridge between the quinolone moiety and the nucleic acid. In fact at physiological conditions the drug is mainly zwitterionic (19) and the presence of a carboxylate group could interfere with the negative charge density of DNA when the drug approached the nucleic acid; however, the Mg-drug complex is positively charged, which would greatly facilitate its reaching the nucleic acid, and the Mg edge of the Mg-drug complex should interact electrostatically with phosphate groups (20, 21) . This is in agreement with the observed decrease in unwinding and binding on increasing ionic strength (5, 9) . However, this would not account for the preference of quinolones for single-stranded regions of the nucleic acid. The fact that binding is poorer for a linear double-helical sequence as compared to a single-stranded sequence suggests that bases not involved in pairing stabilize the drug-Mg complex. Although the drug is not able to intercalate into a DNA double helix (7, 9) , it could form stacking interactions with the bases in a single-stranded region or a distorted B-form in the plasmid, where high unwinding energy is not required. In addition, an increased conformational flexibility of the base could allow optimization of both electrostatic binding through Mg2+ and ir-ir interactions with the planar aromatic system of the drug. Considering the overlapping surface, stacking should be more effective for purine than for pyrimidine bases. As a matter of fact, poly(dG) or poly(G) and poly(A) or poly(dA) bind more tightly than other sequences (6) . Our point is strengthened by the observation that enhanced stability of ternary metal ion-ATP-phenanthroline complexes is caused by stacking interactions involving the Biochemistry: PaRl et A Proc. Natl. Acad. Sci. USA 89 (1992) aromatic portions of ATP and phenanthroline (22) . Indeed, similar behavior is observed when phenanthroline is replaced with Nor in the above system (data not shown).
The (17, 18) . Since from the above equilibria it follows that K1K3 = K2K4, K3 can be evaluated to be =4.2 x 104 M-1. Accordingly, the most favored binding equilibrium corresponds to the interaction between the quinolone-Mg2+ complex and the plasmid. No cooperativity factors are required to fit the data. This is at variance with the model proposed by Shen et al. (7) . It is, however, puzzling that in some experiments cooperativity factors well above the maximum number of Nor molecules bound per plasmid were reported (6) . In eter cannot exceed the number of ligand-binding sites (24) . The reason for this discrepancy is not apparent at the moment.
Cooperativity could possibly arise from bridging of two Nor molecules by Mg2+, similar to the case reported (16) for the binding of chromomycin to DNA. If the above reaction was occurring, we expect that the amount of ternary complex would depend on the square of Nor concentration, which we did not observe.
The optimal concentration of Mg2+ for ternary complex formation falls in the range of intracellular Mg2+ concentrations in bacteria, so that this mode of binding could be biologically relevant. However, the model proposed here does not necessarily imply a correspondence to the situation in vivo in the presence of gyrase. In fact effects at the enzyme level are certainly pertinent to the quinolone mode of action, as indicated by a vast amount of genetic data including sequencing of the mutated enzyme (25) (26) (27) . It is also relevant that the impairment of even very few gyrase molecules could affect the function of the whole chromosome, where a limited number of gyrase binding sites are available (28) .
In addition to a revised DNA-binding model including a role for Mg2+, the formation of Nor-metal ion complexes suggests other interactions, some of which could be pharmacologically relevant. A further step to fully understand the molecular mechanism of action of quinolone drugs is an investigation of ternary gyrase/quinolone/Mg2+ and quaternary gyrase/DNA/quinolone/Mg2+ systems in the presence or absence of ATP.
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